| Literature DB >> 6126406 |
Abstract
Newborns (210) whose mothers received DMPA postpartum were compared with 121 controls for weight gain and for number of infectious illnesses over an average 1.5 years of follow-up. No differences were found except a possible slight increase in infections when DMPA was started 2 days postpartum. Newborns (118) whose mothers received DMPA prior to conception, 10 newborns exposed to DMPA in utero, and 436 controls showed no significant difference in birth weights or incidence of birth defects. Women (101) receiving DMPA for 8 years or more gained more weight than controls, but showed no cancer or increase in hypertension.Entities:
Keywords: Asia; Biology; Birth Weight; Body Weight; Breast Feeding; Cancer; Comparative Studies; Congenital Abnormalities; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods; Demographic Factors; Depo-provera--side effects; Developing Countries; Diseases; Evaluation; Family Planning; Health; Hypertension; Infant Nutrition; Infections; Injectables; Lactation; Longterm Effects; Maternal Physiology; Medroxyprogesterone Acetate--side effects; Nutrition; Physiology; Population; Population Dynamics; Research Methodology; Southeastern Asia; Studies; Thailand; Time Factors
Mesh：
Substances：
Year: 1982 PMID： 6126406 DOI： 10.1016/0020-7292(82)90044-3
Source DB: PubMed Journal: Int J Gynaecol Obstet ISSN： 0020-7292 Impact factor: 3.561